HIGHLIGHTS
- who: Filippo de Marinis et al. from the University of Naples Federico II, Italy have published the research work: Incorporating atezolizumab in the adjuvant setting of non-small cell lung cancer: key discussion points from an expert multidisciplinary panel by Italian Association of Thoracic Oncology, in the Journal: (JOURNAL)
- what: In this opinion article the authors aim to discuss the results obtained in the adjuvant setting of NSCLC with atezolizumab, in light of the recent regulatory approvals by Food and Drug Administration (FDA) and European Medicines Agency (EMA) and its application in clinical practice.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.